Loading clinical trials...
Loading clinical trials...
A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Clinical Trial of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps
Conditions
Interventions
Omalizumab
Placebo
Locations
45
United States
Clinical Research Center of Alabama, LLC
Birmingham, Alabama, United States
Banner University of Arizona Medical Center
Tucson, Arizona, United States
Kaiser Permanente - Rancho Cordova Medical Offices
Rancho Cordova, California, United States
Bensch Clinical Research LLC
Stockton, California, United States
Colorado ENT & Allergy
Colorado Springs, Colorado, United States
Specialist Global Research
Hialeah, Florida, United States
Start Date
November 21, 2017
Primary Completion Date
March 7, 2019
Completion Date
March 7, 2019
Last Updated
March 23, 2020
NCT06914908
NCT05246267
NCT07125586
NCT07268313
NCT05427695
NCT06118554
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions